Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled corticosteroids for young children with episodic wheezing
NL-OMON58987Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluticasone propionate (3 arms), sponsored by Erasmus MC. Primary endpoints: Symptom control, Exacerbation frequency and 1 more. Started Dec 2025; status: recruiting.
02
Drugs
fluticasone propionate
Beyond the preview
Go deeper on NL-OMON58987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58987.